GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CSL CSL.AX · AUD

Health Care · Biotechnology · ASX · 🇦🇺 Australia

Compare

200.77

-0.63%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on CSL

Our reporting

Next results

9 Feb 2027

Due on 9 Feb 2027. Analysts expect earnings of 5.75 a share on revenue of $12.12bn.

Past results

Reported against what analysts expected

17 Aug 202610 Feb 202619 Aug 202511 Feb 202513 Aug 202412 Feb 2024
Earnings per share3.155.683.626.762.746.14
Forecast3.285.843.987.142.705.98
Revenue$10.41bn$12.49bn$11.11bn$13.27bn$10.12bn$11.82bn
Forecast$10.27bn$12.75bn$11.07bn$13.45bn$9.94bn$11.66bn

Key events

  1. 18 Oct 20073-for-1 share split
  2. 2 Nov 20061-to-1 reverse split
  3. 8 Jun 1994Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.